Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Clinical trial NCT05203913 · RECRUITING

Trial details

NCT number: NCT05203913
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma

Start date: 2023-05-01
Primary completion: 2025-12-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.